CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
On-chip Biotechnologies
On-chip Biotechnologies

On-chip Biotechnologies

On-chip Biotechnologies makes microfluidic instruments for cellular and microbial screening.

Operating headquarters
Koganei, Tokyo, JP🇯🇵
Founded
2005
Overview
Compare
Employees
Library

On-chip Biotechnologies develops microfluidic instruments for sorting cells and screening microorganisms. Its On-chip Sort separates cells on disposable chips, while its Droplet Generator and Droplet Selector support droplet-based workflows.

The company's Droplet Selector detects fluorescence from water-in-oil droplets, sorts selected droplets, and dispenses them into well plates. Its applications include microbial discovery, antibody-producing cell screening, and directed enzyme evolution.

On-chip Biotechnologies - Similar Companies

Atrandi Biosciences logo

Atrandi Biosciences

atrandi.com

Microfluidic Innovations logo

Microfluidic Innovations

uFluidix logo

uFluidix

ufluidix.com

Rapid Fluidics logo

Rapid Fluidics

rapidfluidics.com

Parallel Fluidics logo

Parallel Fluidics

CytoRecovery logo

CytoRecovery

cytorecovery.com

Spectrafluidics logo

Spectrafluidics

Clara Biotech logo

Clara Biotech

Hummingbird Nano logo

Hummingbird Nano

Kilobaser logo

Kilobaser

kilobaser.com

Neofluidics logo

Neofluidics

Redbud Labs logo

Redbud Labs

redbudlabs.com

Petl Fluidics logo

Petl Fluidics

petlfluidics.com

CytoMag logo

CytoMag

Vivid Microscopy logo

Vivid Microscopy

On-chip Biotechnologies - Quick Facts

Who are On-chip Biotechnologies' competitors?

Companies similar to On-chip Biotechnologies include Atrandi Biosciences, Microfluidic Innovations, uFluidix and Rapid Fluidics.

When was On-chip Biotechnologies founded?

On-chip Biotechnologies was founded in 2005.

Where is On-chip Biotechnologies' headquarters located?

On-chip Biotechnologies' headquarters is located in Koganei, Tokyo, JP.

On-chip Biotechnologies - Classification

Tags
  • Microfluidics